The Clinical Relevance of Circulating Tumor Necrosis Factor-α in Acute Decompensated Chronic Heart Failure Without Cachexia

This publication has 14 references indexed in Scilit:

• Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
  Journal of the American College of Cardiology, 1996
• AMRINONE SUPPRESSES THE SYNTHESIS OF TUMOR NECROSIS FACTOR-α IN HUMAN MONONUCLEAR CELLS
  Shock, 1994
• Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure.
  Circulation, 1994
• TUMOR NECROSIS FACTOR: A Pleiotropic Cytokine and Therapuetic Target
  Annual Review of Medicine, 1994
• Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.
  Journal of Clinical Investigation, 1993
• Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs.
  Journal of Clinical Investigation, 1992
• Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.
  Heart, 1991
• Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
  New England Journal of Medicine, 1990
• TNF-induced cardiomyopathy
  The Lancet, 1990
• Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential.
  The Journal of Experimental Medicine, 1986